title: Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
abstract: OBJECTIVE
  Complement system plays an important role in host defense mechanisms against microorganisms and tumor cells. To protect themselves from autologous complement-mediated damage, normal host tissues express cell membrane-associated complement regulatory proteins (CRPs). To investigate whether neoplastic endometrial tissues overexpress these proteins to escape complement damage, we examined the distribution of complement receptor type 1 (CR1, CD35), membrane cofactor protein (MCP, CD46), decay-accelerating factor (DAF, CD55), and protectin (MACIF, CD59) on frozen endometrial tissue samples.
  
  
  METHODS
  A total of 54 endometrial tissue samples were collected. Cryosections were obtained of 31 benign and 23 malignant tissue specimens. Tissue sections were stained by immunohistochemical staining procedure using specific antibodies and employing the avidin-biotin technique. Quantitation of the protein content of these CRPs was determined using the Samba 4000 image analysis system.
  
  
  RESULTS
  For all four of the CRPs studied, a statistically significant difference in protein expression between the benign and malignant endometrial tissue specimens (P < 0.0001) was observed.
  
  
  CONCLUSIONS
  Overexpression of all the CRPs studied (CD35, CD46, CD55, CD59) was observed in the malignant as compared with the benign endometrial tissues. The upregulation of these CRPs may promote resistance of the endometrial malignant tissue to complement-mediated damage, thereby allowing the tumor cells to escape from cytolysis and thus promoting carcinogenesis.
authors.affiliation: Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, Minnesota, 55455, USA.
authors.forename: K P
authors.initials: KP
authors.lastname: Murray
authors.forename: S
authors.initials: S
authors.lastname: Mathure
authors.forename: R
authors.initials: R
authors.lastname: Kaul
authors.forename: S
authors.initials: S
authors.lastname: Khan
authors.forename: L F
authors.initials: LF
authors.lastname: Carson
authors.forename: L B
authors.initials: LB
authors.lastname: Twiggs
authors.forename: M G
authors.initials: MG
authors.lastname: Martens
authors.forename: A
authors.initials: A
authors.lastname: Kaul
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000378:metabolism*; D018958:CD55 Antigens / Q000378:metabolism; D018957:CD59 Antigens / Q000378:metabolism; D016889:Endometrial Neoplasms / Q000276:immunology / Q000378:metabolism*; D004717:Endometrium / Q000276:immunology / Q000378:metabolism*; D005260:Female; D006801:Humans; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000378:metabolism; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000378:metabolism*; D017463:Receptors, Complement 3b / Q000378:metabolism
chemical_list: D015703:Antigens, CD; D000951:Antigens, Neoplasm; C497857:CD46 protein, human; D018958:CD55 Antigens; D018957:CD59 Antigens; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D017463:Receptors, Complement 3b